Ziccum AB
Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries liquid biopharmaceuticals, such as vaccines or protein therapeutics into a particle engineered powder product. The company was incorporated in 2017 and is headquartered in Lund, Sweden.
Ziccum AB (ZICC) - Total Assets
Latest total assets as of September 2024: Skr9.85 Million SEK
Based on the latest financial reports, Ziccum AB (ZICC) holds total assets worth Skr9.85 Million SEK as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ziccum AB - Total Assets Trend (2017–2023)
This chart illustrates how Ziccum AB’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ziccum AB - Asset Composition Analysis
Current Asset Composition (December 2023)
Ziccum AB's total assets of Skr9.85 Million consist of 48.0% current assets and 52.0% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 20.0% |
| Accounts Receivable | Skr3.24 Million | 21.6% |
| Inventory | Skr-4.19 Million | -28.0% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr369.00K | 2.5% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2017–2023)
This chart illustrates how Ziccum AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ziccum AB's current assets represent 48.0% of total assets in 2023, an increase from 17.2% in 2017.
- Cash Position: Cash and equivalents constituted 20.0% of total assets in 2023, up from 16.1% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 82.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 21.6% of total assets.
Ziccum AB Competitors by Total Assets
Key competitors of Ziccum AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Ziccum AB - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Ziccum AB generates 0.25x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Ziccum AB is currently not profitable relative to its asset base.
Ziccum AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.36 | 2.51 | 2.53 |
| Quick Ratio | 0.57 | 3.23 | 2.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr-4.68 Million | Skr 8.23 Million | Skr 1.88 Million |
Ziccum AB - Advanced Valuation Insights
This section examines the relationship between Ziccum AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.39 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -55.0% |
| Total Assets | Skr14.97 Million |
| Market Capitalization | $305.34K USD |
Valuation Analysis
Below Book Valuation: The market values Ziccum AB's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Ziccum AB's assets decreased by 55.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Ziccum AB (2017–2023)
The table below shows the annual total assets of Ziccum AB from 2017 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | Skr14.97 Million | -55.02% |
| 2022-12-31 | Skr33.28 Million | -9.80% |
| 2021-12-31 | Skr36.90 Million | -6.91% |
| 2020-12-31 | Skr39.64 Million | +115.49% |
| 2019-12-31 | Skr18.39 Million | +43.88% |
| 2018-12-31 | Skr12.79 Million | +636.04% |
| 2017-12-31 | Skr1.74 Million | -- |